Salus (XLJU:SALR) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XLJU:SALR Salus XLJU:SALR
75 GF Score
Price €67.00
GF Value €32.73
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Salus Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

XLJU:SALR vs MCK, COR, CAH: Short Interest Comparison

For the Medical Distribution subindustry, Salus's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Salus Short Interest vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Salus's Short Interest distribution charts can be found below:

* The bar in red indicates where Salus's Short Interest falls into.


XLJU:SALR
75GF Score
Salus XLJU:SALR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Salus (XLJU:SALR) Overvalued in 2026?

Based on GuruFocus' analysis, Salus stock appears to be overvalued. The current stock price of €67.00 is trading 104.7% above its estimated GF Value™ of €32.73. GuruFocus considers Salus to be Significantly Overvalued.

Key valuation signals for XLJU:SALR:

  • Short Interest:
  • GF Value™: €32.73 vs. price of €67.00 (104.7% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the XLJU:SALR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Salus Business Description

Other Exchanges E3U:Germany
Address Litostrojska cesta 46 A, Ljubljana, SVN, 1000
Salus is a Slovenia-based company engaged in the wholesale and distribution of medical products. It offers medicines, medical devices, medical supplies, dietary supplements, cosmetics to hospitals, pharmacies, and other customers.
75GF Score

Get the complete analysis for XLJU:SALR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€67.00
Price
€32.73
GF Value